Department of Traditional and Western Medical Hepatology, Hebei Provincial Key Laboratory of liver fibrosis in chronic liver diseases, Third Hospital of Hebei Medical University, Shijiazhuang, 050051, Hebei, China.
Lipids Health Dis. 2023 Jul 8;22(1):99. doi: 10.1186/s12944-023-01855-7.
Heme oxygenase 1 (HO-1) has an influential but insufficiently investigated effect on ferroptosis, which is a novel form of programmed cell death and may play an effect on nonalcoholic steatohepatitis (NASH). However, the understanding of the mechanism is limited. Herein, our study aimed to explore the mechanism and role of HO-1 in NASH ferroptosis.
Hepatocyte conditional HO-1 knockout (HO-1) C57BL/6J mice were established and fed a high-fat diet (HFD). Additionally, wild-type mice were fed either a normal diet or a HFD. Hepatic steatosis, inflammation, fibrosis, lipid peroxidation, and iron overload were assessed. AML12 and HepG2 cells were used to investigate the underlying mechanisms in vitro. Finally, liver sections from NASH patients were used to clinically validate the histopathology of ferroptosis.
In mice, HFD caused lipid accumulation, inflammation, fibrosis, and lipid peroxidation, which were aggravated by HO-1. In line with the in vivo results, HO-1 knockdown upregulated reactive oxygen species accumulation, lipid peroxidation, and iron overload in AML12 and HepG2 cells. Additionally, HO-1 knockdown reduced the GSH and SOD levels, which was in contrast to HO-1 overexpression in vitro. Furthermore, the present study revealed that the NF-κB signaling pathway was associated with ferroptosis in NASH models. Likewise, these findings were consistent with the liver histopathology results of NASH patients.
The current study showed that HO-1 could alleviate NASH progression by mediating ferroptosis.
血红素加氧酶 1(HO-1)对铁死亡有影响,但作用尚未得到充分研究,铁死亡是一种新型的程序性细胞死亡方式,可能对非酒精性脂肪性肝炎(NASH)有影响。然而,对其机制的理解有限。在此,我们的研究旨在探索 HO-1 在 NASH 铁死亡中的作用及其机制。
建立了肝细胞条件性 HO-1 敲除(HO-1)C57BL/6J 小鼠,并给予高脂饮食(HFD)。此外,野生型小鼠给予正常饮食或 HFD。评估肝脂肪变性、炎症、纤维化、脂质过氧化和铁过载。体外使用 AML12 和 HepG2 细胞研究潜在机制。最后,使用 NASH 患者的肝组织切片对铁死亡的组织病理学进行临床验证。
在小鼠中,HFD 导致脂质堆积、炎症、纤维化和脂质过氧化,HO-1 加剧了这些变化。与体内结果一致,HO-1 敲低增加了 AML12 和 HepG2 细胞中活性氧积累、脂质过氧化和铁过载。此外,HO-1 敲低降低了 GSH 和 SOD 水平,这与体外 HO-1 过表达相反。此外,本研究表明 NF-κB 信号通路与 NASH 模型中的铁死亡有关。同样,这些发现与 NASH 患者的肝组织病理学结果一致。
本研究表明,HO-1 通过介导铁死亡来减轻 NASH 的进展。